4//SEC Filing
Stout Jay S 4
Accession 0001702969-26-000002
CIK 0001764013other
Filed
Jan 22, 7:00 PM ET
Accepted
Jan 23, 4:21 PM ET
Size
5.3 KB
Accession
0001702969-26-000002
Research Summary
AI-generated summary of this filing
Immunovant (IMVT) CTO Jay S Stout Sells 1,977 Shares
What Happened
Jay S Stout, Chief Technology Officer of Immunovant, sold 1,977 shares on Jan 21, 2026 at $26.03 per share, generating proceeds of about $51,461. The sale was not a discretionary trade — it was executed to cover tax withholding related to RSUs that vested.
Key Details
- Transaction date and price: Jan 21, 2026 — 1,977 shares sold at $26.03 each.
- Total value: approximately $51,461.
- Shares owned after transaction: not specified in the provided filing.
- Footnote: On April 17, 2023 the reporting person was granted 100,000 RSUs; 6,250 of those RSUs vested on Jan 17, 2026. This sale represented a mandated "sell-to-cover" to satisfy tax withholding for the RSU vesting (not a voluntary sale by the insider).
- Filing timeliness: Report filed Jan 23, 2026 (appears timely — within the SEC’s two-business-day Form 4 reporting window).
Context
Sell-to-cover transactions are routine when restricted stock units vest and the company or holder elects to sell some shares to pay taxes. Such sales generally reflect tax settlement mechanics rather than an insider signaling a view on the company’s stock.
Insider Transaction Report
Form 4
Immunovant, Inc.IMVT
Stout Jay S
Chief Technology Officer
Transactions
- Sale
Common Stock
[F1]2026-01-21$26.03/sh−1,977$51,461→ 197,634 total
Footnotes (1)
- [F1]On April 17, 2023, the holder was granted 100,000 restricted stock units ("RSUs"), as previously reported on a Form 4 filed on April 19, 2023, of which 6,250 of these RSUs vested on January 17, 2026. The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of these RSUs. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.
Signature
/s/ Tiago Girao, attorney-in-fact for Jay Stout|2026-01-23
Documents
Issuer
Immunovant, Inc.
CIK 0001764013
Entity typeother
Related Parties
1- filerCIK 0001702969
Filing Metadata
- Form type
- 4
- Filed
- Jan 22, 7:00 PM ET
- Accepted
- Jan 23, 4:21 PM ET
- Size
- 5.3 KB